Johnson & Johnson Commits $1 Billion to Expand ACUVUE Contact Lens Manufacturing Amid Quiet Revolution in Medical Supply Chains

On June 15, Johnson & Johnson announced that it wouldInvestment Exceeding $1 Billion, expanding its manufacturing base in Jacksonville, Florida.

This investment targets core consumer healthcare products——ACUVUE® Contact Lenses, including the construction of a new distribution center and the introduction of advanced manufacturing and packaging technologies, is expected toFull production will commence in 2028.

Johnson & Johnson’s ties to Jacksonville date back to 1981. Over the past 44 years, the city has become a core manufacturing hub for Johnson & Johnson’s Vision Care business."This investment reinforces our long-standing belief that advanced manufacturing in the United States is essential to delivering innovative, high-quality healthcare solutions to patients worldwide,"Johnson & Johnson Chairman and CEO Joaquin Duato stated in a release."By further strengthening our vision care business in Jacksonville,"We are enhancing the resilience of the US supply chain."

This investment is not an isolated move. Since 2026,Johnson & Johnson is intensively advancing its manufacturing footprint in the United States.

Total of Two InvestmentsOver $3 billion, including the current Jacksonville expansion, are all part of Johnson & Johnson's previously committed$55 Billion U.S. Investment Plan（Covering manufacturing, R&D, and technology, continuing until early 2029). In Q1 2026, Johnson & Johnson's MedTech business achieved global sales of $8.6 billion., year-on-year increase4.6%, with growth in the U.S. market5.9%, overseas increase3.2%。

Johnson & Johnson Is Not the Only OneMedical Giants Expanding Production on a Large Scale in the US. TariffsPressure and Various Uncertainties Are Reshaping the Global Manufacturing Landscape:

• Lilly Invests $27 Billion to Build 4 New U.S. Factories;

• AstraZeneca Adds $2 Billion for Manufacturing and R&D;

• Apple Announces $500 Billion Investment Plan (Including Wearable Medical Devices);

  
  

Senator Rick Scott stated bluntly, “A $1 billion investment means a stronger national economy,”Reduced Reliance on Foreign Medical Products。"

Johnson & Johnson's current expansion, on the surface, is a facility upgrade,Underlying LogicAt a time when supply chain security has become a core competitive factor, this represents a strategic bet on the resilience of domestic manufacturing.

As global giants are bringing production capacity back to their home countries,Supply Strategy, Pricing System, and Pace of Domestic Substitution in the Chinese Market, will usher in new variables.